Page last updated: 2024-08-24

halofuginone and Carcinoma, Lewis Lung

halofuginone has been researched along with Carcinoma, Lewis Lung in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Y; Gong, L; Hou, H; Ji, K; Liu, N; Liu, W; Wang, P; Wang, Y; Zhao, L1

Other Studies

1 other study(ies) available for halofuginone and Carcinoma, Lewis Lung

ArticleYear
Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer.
    Oncotarget, 2016, Nov-01, Volume: 7, Issue:44

    Topics: Animals; Antineoplastic Agents; Benzamides; Carcinoma, Lewis Lung; Cell Movement; Dioxoles; Epithelial-Mesenchymal Transition; Female; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Piperidines; Quinazolinones; Smad Proteins; Transforming Growth Factor beta1; Xenograft Model Antitumor Assays

2016